NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The federal government says it’s in close contact with its American partners as the Biden administration escalates efforts to halt Canada’s tax on large foreign digital services companies.Read More